Cheng K K F
Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong, 804A, Esther Lee Building, Shatin, New Territories, Hong Kong.
Eur J Oncol Nurs. 2004 Dec;8(4):341-9. doi: 10.1016/j.ejon.2004.04.002.
Oral care is of great importance in the prevention of chemotherapy-induced oropharyngeal mucositis. Although considerable attention has been given in improving oral care practices, patients' acceptance and tolerance of oral rinses is a continuing problem in oral care. A randomized crossover design was used to determine the relative acceptability and tolerability of chlorhexidine and benzydamine oral rinse agents in children receiving chemotherapy. At the end of the study, each subject was asked to compare these two agents in relation to stinging and taste, as well as his/her perception in reducing mucositis. Thirty-four children aged 6-17 years completed two courses of chemotherapy during which they alternately practiced oral care using chlorhexidine then benzydamine or benzydamine then chlorhexidine. All of the children tolerated the agents well and continued with rinsing throughout the study. Only a few children had to resort to diluting the agents with normal saline or water. Fifty-nine percent of children reported that the stinging associated with benzydamine was more accepted than chlorhexidine. The taste of both these agents was accepted by 50% of children. Approximately 60% of children reported that chlorhexidine was more helpful than benzydamine in reducing mucositis. About 47% and 50% of them preferred chlorhexidine and benzydamine in their subsequent chemotherapy, respectively. In conclusion, chlorhexidine and benzydamine are acceptable and well-tolerated by children over the age 6 years old.
口腔护理在预防化疗引起的口腔黏膜炎方面非常重要。尽管在改进口腔护理方法上已给予了相当多的关注,但患者对口腔冲洗液的接受度和耐受性仍是口腔护理中持续存在的问题。采用随机交叉设计来确定洗必泰和苄达明口腔冲洗剂在接受化疗的儿童中的相对可接受性和耐受性。在研究结束时,要求每位受试者比较这两种药剂在刺痛感、味道以及减轻黏膜炎方面的感受。34名6至17岁的儿童完成了两个疗程的化疗,在此期间他们交替使用洗必泰然后苄达明或苄达明然后洗必泰进行口腔护理。所有儿童对这两种药剂耐受性良好,并且在整个研究过程中都持续进行冲洗。只有少数儿童不得不使用生理盐水或水稀释药剂。59%的儿童报告称,与洗必泰相比,苄达明引起的刺痛更容易接受。50%的儿童接受这两种药剂的味道。约60%的儿童报告称,洗必泰在减轻黏膜炎方面比苄达明更有帮助。在后续化疗中,分别约有47%和50%的儿童更喜欢洗必泰和苄达明。总之,6岁以上儿童可接受洗必泰和苄达明,且耐受性良好。